Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

MD stock hub

Pediatrix Medical Group, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

MDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.9B

NYSE

Market data

Live price

Current market quote for this ticker.

Current price

In the news

Latest news · MD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E10.4

P25 12.3P50 18.4P75 33.1

Trailing P/E11.4

P25 14.9P50 23.2P75 38.5

ROE20.9

P25 -105.6P50 -46.5P75 -3.1

ROIC16.8

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All MD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

259

Groups with data

Currency

USD

Showing 259 of 259 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000893949
Company name	Pediatrix Medical Group, Inc.
Country	United States
Country code	US
Cusip	58502B106
Employees	4,280
Employees Change	160%
Employees Change Percent	3.88
Enterprise value	$2.2B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	Medical Care Facilities
IPO Date	1995-09-19
Isin	US58502B1061
Last refreshed	2026-05-10
Market cap	$1.9B
Market cap category	Small-Cap
Price	$23.51
Price currency	USD
Rev Per Employee	451,328.5x
Sector	Healthcare
Sic	8060
Symbol	MD
Website	https://www.pediatrix.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	9.24%
EV Earnings	12.55x
EV Sales Forward	1.09x
EV/EBIT	9.15x
EV/EBITDA	8.36x
EV/FCF	9.21x
EV/Sales	1.13x
FCF yield	12.59%
Forward P/E	10.38x
P/B ratio	2.14x
P/E ratio	11.39x
P/S ratio	0.98x
PE Ratio5 Y	22.88x
PS Forward	0.94x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	12.37%
EBITDA Margin	13.54%
FCF margin	12.29%
Gross margin	26.09%
Gross Profit	$504M
Gross Profit Growth	9.07%
Gross Profit Growth Q	10.06%
Gross Profit Growth3 Y	3.51%
Gross Profit Growth5 Y	2.12%
Net Income	$174.2M
Net Income Growth Q	42.61%
Net Income Growth Quarters	6%
Net Income Growth Years	1%
Net Income Growth3 Y	19.64%
Pretax Margin	11.76%
Profit Margin	9.02%
Profit Per Employee	$40,706
Profitable Years	1
ROA	7.35
Roa5y	5.11
ROCE	14.68
ROE	20.89
Roe5y	4.24
ROIC	16.81
Roic5y	13.14

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-10.25%
Cagr15y	-2.9%
Cagr1y	63.89%
Cagr20y	-0.32%
Cagr3y	19.75%
Cagr5y	-6.04%
EPS Growth Q	50
EPS Growth Quarters	6
EPS Growth Years	1
EPS Growth3 Y	19.29
FCF Growth	22.13%
FCF Growth3 Y	21.01%
FCF Growth5 Y	0.09%
OCF Growth	20.7%
OCF Growth10 Y	-4.01%
OCF Growth3 Y	16.53%
OCF Growth5 Y	-0.43%
Revenue Growth	-2.25x
Revenue Growth Q	3.89x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-0.83x
Revenue Growth5 Y	2.12x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.95
Assets	$2.1B
Cash	$329M
Current Assets	$587M
Current Liabilities	$442.6M
Debt	$629.7M
Debt EBITDA	$2.28
Debt Equity	$0.72
Debt FCF	$2.65
Equity	$878.6M
Interest Coverage	6.81
Liabilities	$1.2B
Long Term Assets	$1.5B
Long Term Liabilities	$749.1M
Net Cash	$-300.7M
Net Cash By Market Cap	$-15.95
Net Debt EBITDA	$1.15
Net Debt Equity	$0.34
Net Debt FCF	$1.27
Tangible Book Value	$-405.6M
Tangible Book Value Per Share	$-5.06
WACC	7.17

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.33
Net Working Capital	$19.7M
Quick ratio	1.28
Working Capital	$144.4M
Working Capital Turnover	$10.58

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.14%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-66.09%
1Y total return	63.83%
200-day SMA	19.65
3Y total return	71.73%
50-day SMA	21.27
50-day SMA vs 200-day SMA	50over200
5Y total return	-26.76%
All Time High	86.09
All Time High Change	-72.69%
All Time High Date	2015-08-18
All Time Low	1.5
All Time Low Change	1,467.33%
All Time Low Date	1999-10-21
ATR	1.01
Beta	0.71
Beta1y	0.82
Beta2y	0.57
Ch YTD	9.91
High	23.74
High52	24.99
High52 Date	2025-11-28
High52ch	-5.92%
Low	22.91
Low52	11.84
Low52 Date	2025-08-01
Low52ch	98.56%
Ma50ch	10.55%
Premarket Change Percent	0.04
Premarket Price	$22.94
Premarket Volume	1,010
Price vs 200-day SMA	19.63%
RSI	59.87
RSI Monthly	64.88
RSI Weekly	64.55
Sharpe ratio	1.24x
Sortino ratio	2.28
Total Return	-1.14%
Tr YTD	9.91
Tr15y	-35.68%
Tr1m	8.14%
Tr1w	3.34%
Tr3m	12.54%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	2
Analyst Price Target Top	$22.5
Analyst Ratings	Hold
Analyst Ratings Top	Hold
Earnings EPS Estimate	$0.37
Earnings EPS Estimate Growth	12.12
Earnings Revenue Estimate	466,054,808x
Earnings Revenue Estimate Growth	1.68x
Operating Income	$239M
Operating Income Growth	20.68
Operating Income Growth Q	20.34
Operating Income Growth3 Y	8.03
Operating Income Growth5 Y	6.3
Operating margin	12.37
Price target	$20.5
Price Target Change	$-12.8
Price Target Change Top	$-4.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	79,069,163%
Float Percent	98.6%
Net Borrowing	-22,451,000
Shares Insiders	1.34%
Shares Institutions	107.46%
Shares Out	80,187,937
Shares Qo Q	-1.59%
Shares Yo Y	1.14%
Short Float	4.37%
Short Ratio	3.99
Short Shares	4.31

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$218.3M
Average Volume	798,384.5x
Bv Per Share	10.96
CAPEX	$-21.4M
Ch10y	-66.09
Ch15y	-35.68
Ch1m	8.14
Ch1w	3.34
Ch1y	63.83
Ch20y	-6.17
Ch3m	12.54
Ch3y	71.73
Ch5y	-26.76
Ch6m	7.21
Change	2.53%
Change From Open	2.04
Close	22.93
Days Gap	0.48
Depreciation Amortization	22,614,000
Dollar Volume	18,778,941.6
Earnings Date	2026-05-05
Earnings Time	bmo
EBIT	$239M
EBITDA	$261.6M
EPS	$2.06
F Score	7
FCF	$237.3M
FCF EV Yield	10.86x
FCF Per Share	$2.96
Financing CF	-129,094,000
Fiscal Year End	December
Founded	1,979
Goodwill	1,268,248,000
Graham Number	22.5685
Graham Upside	-4
Income Tax	$53M
Investing CF	-22,811,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Date	2013-12-20
Last Split Type	Forward
Last10k Filing Date	2026-02-19
Lynch Fair Value	$40.55
Lynch Upside	72.49
Ma150	20.99
Ma150ch	11.99%
Ma20	22.62
Ma20ch	3.93%
Net CF	106,802,000
Next Earnings Date	2026-08-04
Open	23.04
Optionable	Yes
P FCF Ratio	7.94
P OCF Ratio	7.29
Position In Range	72.29
Ppne	77,965,000
Pre Close	22.93
Price Date	2026-05-08
Price EBITDA	$7.21
Relative Volume	1x
Revenue	1,931,686,000x
SBC By Revenue	0.99x
Share Based Comp	19,065,000
Tax By Revenue	2.74x
Tax Rate	23.31%
Tr20y	-6.17%
Tr6m	7.21%
Us State	Florida
Volume	798,764
Z Score	2.1

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does MD pay a dividend?

Capital-return profile for this ticker.

Performance

MD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns MD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+107.5%

Float: +98.6% of shares outstanding

Insider ownership

+1.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

MD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

59.9

Neutral momentum band

Price vs 200-day MA

+19.6%

50/200-day relationship not available

Beta (5Y)

0.71

Less volatile than the market

Sharpe ratio

1.24

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About MD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current MD stock rating?

Pediatrix Medical Group, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full MD analysis?

The full report lives at /stocks/MD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for MD?

The latest report frames MD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the MD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.